PowerNovo2: A generative flow-based approach to non-autoregressive de novo peptide sequencing

0Citations
Citations of this article
1Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Proteomics utilizes tandem mass spectrometry (MS/MS) to determine peptide sequences, traditionally through database searches constrained by prior knowledge. De novo sequencing offers a database-free alternative but struggles with accurately modeling complex MS/MS spectra. Most current tools use autoregressive decoding, which is prone to error propagation and computationally slow. Here we present PowerNovo2, a non-autoregressive model based on generative normalizing flows. By leveraging variational inference, it effectively captures intricate token dependencies and peptide-level uncertainties. PowerNovo2 outperforms existing de novo tools in accuracy and speed, matching state-of-the-art autoregressive models like Casanovo while being 4.3 times faster. It also demonstrates competitive performance against other non-autoregressive methods such as π-PrimeNovo, particularly on long peptides and low-resolution spectra. As the first flow-based de novo sequencer, PowerNovo2 provides a scalable, accurate solution for large-scale proteomic applications.

Cite

CITATION STYLE

APA

Petrovskiy, D. V., Nikolsky, K. S., Rudnev, V. R., Kulikova, L. I., Butkova, T. V., Malsagova, K. A., … Kaysheva, A. L. (2026). PowerNovo2: A generative flow-based approach to non-autoregressive de novo peptide sequencing. PLoS Computational Biology, 22(5), e1014298. https://doi.org/10.1371/journal.pcbi.1014298

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free